David Muller came close to writing the final ...
EyeGate Pharmaceuticals had hit a wall. Its v...
The combination of Pfizer and Allergan certai...
Glaucoma once might have been a boring or sle...
Jeff Heier, MD, is the Director of the Vitreo...
CEO Wolfgang Tolle joined VisionCare last yea...
Glaucoma specialist Dr. Richard Lewis says gl...
Clinical trials of complement inhibitors rece...
Following his successful exit from WaveTec, T...
The complement system is a promising target f...